| Sandoz Pharmaceuticals AG - Mometasonfuroat Sandoz, Nasenspray | | 61899 | | 01 | | Mometasonfuroat Sandoz | | Nasenspray | | R01AD09 | | Mometasone | | 04.04.2012 | | |
| | Composition | | mometasoni-17 furoas 0.5 mg ut mometasoni-17 furoas monohydricus 0.51731 mg, cellulosum microcristallinum et carmellosum natricum, glycerolum, acidum citricum monohydricum, natrii citras dihydricus, polysorbatum 80, benzalkonii chloridum 0.2 mg, aqua ad iniectabile, ad suspensionem pro 1 g corresp., mometasoni-17 furoas 50 µg pro dosi, doses pro vase 140. | | Packungsbestandteile | | Nasal spray | | | | | | | | | BAG: Active Agent | Dose |
|---|
| Mometasone 17 Furoate | 0.05 mg |
| | | | Inactive agents | Dose |
|---|
| Citric Acid Monohydrate | | | Benzalkonium Chloride | 0.2 mg/g | | Carmellose Sodium | | | Cellulosum Microcristallinum | | | Glycerol | | | Mometasone 17 Furoate | 0.5 mg/g | | Natrii Citras Dihydricus | | | Polysorbatum 80 | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 140 unidose(s) | 7.73 | 17.65 | B | SL | Yes | | 002 | 3 x 140 unidose(s) | 19.70 | 37.85 | B | SL | Yes |
|
|
